New
Clinical trials are experiments that test how well new drugs, treatments or devices work in people. Trials progress through Phases I-IV to test a drug candidate, find the appropriate dosage, and look for side effects. The goal is to determine whether a medicine is both safe and effective.
Drug candidates that have entered into clinical trials or pending approval by the U.S. Food and Drug Administration (FDA) are often said to be "in the pipeline." Our own Vitiligo Drug Pipeline Analysis and Market Insights analyzes and monitors the entire development landscape along with the trends shaping and driving the vitiligo market. For example, Ruxolitinib cream (currently marketed under the brand name Opzelura) for vitiligo treatment is on FDA's fast track.
On the Trials Hub page you'll find a comprehensive listing with current clinical trials, including the most recent announcements from Vitiligo Center at UMass in Boston, MA or Tel-Aviv Sourasky Medical Center in Israel.
FAQOther Questions
- I have a new job - should I tell colleagues about my vitiligo?
If you are starting a new job and you are concerned about stares and questions about your skin, try a proactive approach. When the time is right and you are feeling comfortable,...
- What is the best therapy for localized vitiligo?
An investigation from Egypt cites early systemic immunomodulation for recent localized vitiligo as a “successful approach” for achieving early control of disease activity. It he...
- How long does it take to treat vitiligo?
Treatment results will vary by person and type of vitiligo. The rule of thumb is that you will need to allow at least 3 to 6 months before you begin to see results from any trea...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.